Prognostic Impact of Hyperglycemia in Patients with Locally Advanced Squamous Cell Carcinoma of Cervix Receiving Definite Radiotherapy
|
|
- Jack Griffith
- 6 years ago
- Views:
Transcription
1 Prognostic Impact of Hyperglycemia in Patients with Locally Advanced Squamous Cell Carcinoma of Cervix Receiving Definite Radiotherapy KCCH 김문홍
2 DM and prediabetes in cancer Negative impact on survival in cancer patients receiving surgery and/or chemotherapy ; GI, breast, liver, pancreas, lung, and hematologic malignancies Little evaluation for survival impact in cancer treated primarily by radiation ; cervix, head and neck Nat Clin Pract Oncol 2(1): Cancer 115(5): Cancer 110(1): J Clin Oncol 24(31):
3 Cancer-associated systemic inflammation Neutrophilia and lymphopenia NLR: neutrophil lymphocyte ratio Association with tumor extent and aggressiveness Poor prognostic factor in most malignancy including cervical cancer Anticancer Res 32(4): Int J Clin Oncol 20(5):
4 Objective Survival impact of hyperglycemia in locally advanced cervical cancer treated by primary RT or CCRT
5 Methods Retrospective analysis Inclusion criteria Squamous cell carcinoma FIGO stage IIB IVA Year of diagnosis: 2004~2013 Glucose level at initial W/U Primary RT or CCRT Exclusion criteria Other malignancy within 5 years Incomplete treatment Primary surgery
6 Flow diagram for patients enrollment Locally Advanced Cervical Cancer Stage IIB ~ IVA Squamous cell carcinoma from January 2004 to December 2013 N=282 Primary RT N=260 Exclusion 1 Primary surgery: 8 Initially treated at other site: 4 Incomplete treatment: 8 Accompanying other cancer : 2 Exclusion 2 No initial glucose level: 4 No tumor size description: 2 F/U loss within 3 months: 13 N= 242
7 Random Plasma Glucose and NLR Measured as a initial W/U: CBC and admission panel Cut-off value Random plasma glucose: 126mg/dL NLR: 2.9 (median value) Diagnosis criteria for Diabetes (American Diabetes Association) A1C 6.5% Or Fasting plasma glucose (FPG) 126 mg/dl Or 2-h PG 200 mg/dl on 75gOGTT Or classic Sx & random plasma glucose 200 mg/dl
8 Methodology Survival analysis (PFS and OS) Glucose < 126mg/dL vs. 126 mg/dl In total patients In non-dm patients DM vs. non-dm Metformin vs. other drug for patients with DM NLR <2.9 vs. 2.9 Multivariate & Cox regression analysis for non-dm patients
9 Methodology PFS: From: date of diagnosis To: date of first recurrence or last f/u date OS: used survival data obtained from national database From: date of diagnosis To: date of death or January 1 st 2014 (date of confirmation for life or death or last f/u date)
10 General characteristics No. of patients 242 Age, years (range) 58* (30-88) Follow up duration, months (range) 52* ( ) BMI, kg/m * ( ) Hemoglobin, g/dl 11.8* ( ) Random plasma glucose, mg/dl (range) 110* (69-364) Total cholesterol, mg/dl 177* (89-309) Albumin, g/dl 4.2* ( ) NLR (neutrophil lymphocyte ratio) 2.9* ( ) Tumor diameter, cm (range) 5* (1.5-10) SCC, ng/ml 8* (1-259) Diabetes mellitus (%) 28 (11.6) FIGO stage (%) IIB 168 (69.4) III 57 (23.6) IVA 17 (7.0) Treatment (%) RT only 48 (19.8) CCRT 194 (80.2) Lymph nodes enlargement (%) no 88 (36.4) yes 154 (63.6) Treatment result (%) Complete remission 215 (88.8) Persistent disease 27 (11.2) * median
11 Comparisons according to random plasma glucose Random plasma glucose, mg/dl < p No. of patients Age, years 57.3 ± ± BMI, kg/m ± ± Hemoglobin, g/dl ± ± Total cholesterol, mg/dl ± ± Albumin, g/dl 4.18 ± ± NLR (neutrophil lymphocyte ratio) 3.16 ± ± Tumor diameter, cm 53.3 ± ± SCC, ng/ml 20.0 ± ± DM <0.001 no 154 (95.1) 60 (75.0) yes 8 (4.9) 20 (25.0) FIGO stage (%) IIB 107 (66.0) 61 (76.3) III 43 (26.5) 14 (17.5) IVA 12 (7.4) 5 (6.3) Treatment (%) RT only 32 (19.8) 16 (20.0) CCRT 130 (80.2) 64 (80.0)
12 Comparisons according to NLR NLR < p No. of patients Age, years 59.9± ± BMI, kg/m ± ± Hemoglobin, g/dl 11.9± ±2.4 <0.001 Random plasma glucose, mg/dl 118.5± ± Total cholesterol, mg/dl 188.9± ± Albumin, g/dl 4.3± ±0.6 <0.001 Tumor diameter, cm 4.8± ±1.8 <0.001 SCC, ng/ml 17.0± ± DM no 104 (87.4) 110 (89.4) yes 15 (12.6) 13 (10.6) FIGO stage (%) IIB 92 (77.3) 76 (61.8) III 23 (19.3) 34 (27.6) IVA 4 (3.4) 13 (10.6) Treatment (%) RT only 99 (83.2) 95 (77.2) CCRT 20 (16.8) 28 (22.8)
13 KM-survival curves Random plasma glucose in total patients (n=242) 126mg/dL 126mg/dL < 126mg/dL < 126mg/dL P=0.039 P=0.009
14 KM-survival curves Random plasma glucose in non-dm patients (n=214) 126mg/dL 126mg/dL < 126mg/dL < 126mg/dL P=0.053 P=0.035
15 KM-survival curves DM vs. non-dm in total patients (n=242) DM DM Non-DM Non-DM P=0.618 P=0.084
16 KM-survival curves Metformin vs. other drug in DM patients (n=28) Metformin Metformin Other drugs Other drugs P=0.618 P=0.174
17 PFS for non-dm patients (n=214) Progression-free survival Factor Number Univariate Multivariate HR P HR P Age > BMI> Albumin<3.5g/dL Total cholesterol Tumor size > 5cm Glucose 126 mg/dl NLR FIGO stage III or IV CCRT
18 OS for non-dm patients (n=214) Overall survival Factor Number Univariate Multivariate HR P HR P Age > BMI> Albumin<3.5g/dL Total cholesterol Tumor size > 5cm Glucose 126 mg/dl NLR FIGO stage III or IV CCRT < <0.001
19 Metabolism and Cancer Cancer cells depend on glycolysis rather than oxydative phosphorylation due to hypoxic microenvironment. Tumor hypoxia causes resistance to radiation.
20 Transiently reducing oxygen consumption is a highly effective way to reduce tumor hypoxia. (Secomb et al., 1995) Attacking hypoxia by pharmacologically reducing oxygen demand is a highly innovative paradigm shift High dose glucose can modestly downregulate mitochondrial function in experimental tumors through the induction of the Crabtree effect.(snyder et al., 2001) A bolus of glucose can shift cellular energetics to glycolysis away from oxidative phosphorylation J Clin Oncol 32(26):
21
22 Our hypothesis Cancer cell s dependence on glycolysis may be an adaptation response to tissue hypoxia not an inherited characteristics. Inducing glycolysis may have positive effect on radiation sensitivity by reducing oxygen consumption There may be an association between glucose concentration and radiation sensitivity
23 Limitation Selection bias -> prospective study Random plasma glucose Using mean value of multiple measurements during RT prospective study using fasting plasma glucose
24 Conclusion Hyperglycemia was associated with improved PFS in patients with locally advanced squamous cell carcinoma of cervix treated with primary RT or CCRT Hyperglycemia is suggested to enhance sensitivity to radiotherapy Mild obesity seems to be associated with improved overall survival NLR, a marker representing systemic inflammation, is associated with extent of disease and PFS
COX-2 inhibitor and irradiation. Saitama Cancer Center Kunihiko Kobayashi MD, PhD
COX-2 inhibitor and irradiation Saitama Cancer Center Kunihiko Kobayashi MD, PhD Synthesis of prostaglandins from arachidonic acid by cyclooxygenase (COX) enzymes JNCI 95:1440, 2003 Difference between
More informationGCIG Rare Tumour Brainstorming Day
GCIG Rare Tumour Brainstorming Day Relatively (Not So) Rare Tumours Adenocarcinoma of Cervix Keiichi Fujiwara, Ros Glasspool Benedicte Votan, Jim Paul Aim of the Day To develop at least one clinical trial
More informationClinicopathological Factors Affecting Distant Metastasis Following Loco-Regional Recurrence of breast cancer. Cheol Min Kang 2018/04/05
Abstract No.: ABS-0075 Clinicopathological Factors Affecting Distant Metastasis Following Loco-Regional Recurrence of breast cancer 2018/04/05 Cheol Min Kang Department of surgery, University of Ulsan
More informationHYPERTHERMIA in CERVIX and VAGINA CANCER. J. van der Zee
HYPERTHERMIA in CERVIX and VAGINA CANCER J. van der Zee ESTRO 2006 Deep hyperthermia in Rotterdam HYPERTHERMIA in CERVIX and VAGINA CANCER ESTRO 2006 Hyperthermia and radiotherapy in primary advanced cervix
More informationClinical Outcome of Reconstruction With Tissue Expanders for Patients With Breast Cancer and Mastectomy
Clinical Outcome of Reconstruction With Tissue Expanders for Patients With Breast Cancer and Mastectomy Mitsui Memorial Hospital Department of Breast and Endocine surgery Daisuke Ota No financial support
More informationTreatment results of proton beam therapy with chemo-radiotherapy for stage I-III esophageal cancer
Treatment results of proton beam therapy with chemo-radiotherapy for stage I-III esophageal cancer Nobukazu Fuwa 1, Akinori Takada 2 and Takahiro Kato 3 1;Departments of Radiology, Hyogo Ion Beam Medical
More informationPrognostic factors and treatment outcome after radiotherapy in cervical cancer patients with isolated para-aortic lymph node metastases
Original Article J Gynecol Oncol Vol. 24, No. 3:229-235 pissn 2005-0380 eissn 2005-0399 Prognostic factors and treatment outcome after radiotherapy in cervical cancer patients with isolated para-aortic
More informationManagement of high risk early cervical cancer - a view of surgeon Dan DY Kim, M.D., Ph.D.
Management of high risk early cervical cancer - a view of surgeon Dan DY Kim, M.D., Ph.D. Department of Obstetrics and Gynecology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea
More informationOnly Estrogen receptor positive is not enough to predict the prognosis of breast cancer
Young Investigator Award, Global Breast Cancer Conference 2018 Only Estrogen receptor positive is not enough to predict the prognosis of breast cancer ㅑ Running head: Revisiting estrogen positive tumors
More informationWorkshop LA RADIOTERAPIA DEI TUMORI RARI I TIMOMI : INDICAZIONI
XXI CONGRESSO NAZIONALE AIRO Genova, 19-22 novembre 2011 Workshop LA RADIOTERAPIA DEI TUMORI RARI I TIMOMI : INDICAZIONI PIERA NAVARRIA Unità Operativa di Radioterapia e Radiochirurgia Humanitas Cancer
More informationOutcome of DLBCL patients over 80 years: A retrospective survey from 4 Institutions
Outcome of DLBCL patients over 80 years: A retrospective survey from 4 Institutions AA Moccia, S Gobba, A Conconi, S Diem, L Cascione, K Aprile von Hohenstaufen, W Gulden Sala, A Stathis, F Hitz, G Pinotti,
More informationLocoregional treatment Session Oral Abstract Presentation Saulo Brito Silva
Locoregional treatment Session Oral Abstract Presentation Saulo Brito Silva Background Post-operative radiotherapy (PORT) improves disease free and overall suvivallin selected patients with breast cancer
More informationRESEARCH ARTICLE. Kuanoon Boupaijit, Prapaporn Suprasert* Abstract. Introduction. Materials and Methods
RESEARCH ARTICLE Survival Outcomes of Advanced and Recurrent Cervical Cancer Patients Treated with Chemotherapy: Experience of Northern Tertiary Care Hospital in Thailand Kuanoon Boupaijit, Prapaporn Suprasert*
More informationThe clinicopathological features and treatment modalities associated with survival of neuroendocrine cervical carcinoma in a Chinese population
Zhang et al. BMC Cancer (2019) 19:22 https://doi.org/10.1186/s12885-018-5147-2 RESEARCH ARTICLE Open Access The clinicopathological features and treatment modalities associated with survival of neuroendocrine
More informationThe Impact of Adjuvant Chemotherapy in Pulmonary Large Cell Neuroendocrine Carcinoma (LCNC)
The Impact of Adjuvant Chemotherapy in Pulmonary Large Cell Neuroendocrine Carcinoma (LCNC) Disclosure None Background Torino, Italy LCNC Rare tumor (2% to 3% all resected primary lung cancers) Preoperative
More information3/8/2014. Case Presentation. Primary Treatment of Anal Cancer. Anatomy. Overview. March 6, 2014
Case Presentation Primary Treatment of Anal Cancer 65 year old female presents with perianal pain, lower GI bleeding, and anemia with Hb of 7. On exam 6 cm mass protruding through the anus with bulky R
More informationOutcomes and prognostic factors of cervical cancer after concurrent chemoradiationjog_
bs_bs_banner doi:10.1111/j.1447-0756.2012.01871.x J. Obstet. Gynaecol. Res. Vol. 38, No. 11: 1315 1320, November 2012 Outcomes and prognostic factors of cervical cancer after concurrent chemoradiationjog_1871
More informationSQUAMOUS CELL CARCINOMA OF THE ORAL CAVITY IN THE ELDERLY
ORIGINAL ARTICLE SQUAMOUS CELL CARCINOMA OF THE ORAL CAVITY IN THE ELDERLY Yi-Shing Leu 1,2,3 *, Yi-Fang Chang 4, Jehn-Chuan Lee 1, Chung-Ji Liu 2,5,6, Hung-Tao Hsiao 7, Yu-Jen Chen 8, Hong-Wen Chen 8,9,
More informationCorrelation of intermediate risk factors with prognostic factors in patients with early cervical cancer
대한부인종양콜포스코피학회제 24 차학술대회 Correlation of intermediate risk factors with prognostic factors in patients with early cervical cancer Seoul National University Bundang Hospital Eun Jung Soh, M.D. Cervical cancer
More informationPlate Exposure after Reconstruction by Plate and Anterolateral Thigh Flap in Head and Neck Cancer Patients with composite mandibular Defects
Plate Exposure after Reconstruction by Plate and Anterolateral Thigh Flap in Head and Neck Cancer Patients with composite mandibular Defects Chia-Hsuan Tsai/ Huang-Kai Kao M. D. Introduction Malignant
More informationType 2 Diabetes and Cancer: Is there a link?
Type 2 Diabetes and Cancer: Is there a link? Sonali Thosani, MD Assistant Professor Department of Endocrine Neoplasia & Hormonal Disorders MD Anderson Cancer Center No relevant financial disclosures Objectives
More informationDe-Escalate Trial for the Head and neck NSSG. Dr Eleanor Aynsley Consultant Clinical Oncologist
De-Escalate Trial for the Head and neck NSSG Dr Eleanor Aynsley Consultant Clinical Oncologist 3 HPV+ H&N A distinct disease entity Leemans et al., Nature Reviews, 2011 4 Good news Improved response to
More informationPrognostic significance of positive lymph node number in early cervical cancer
1052 Prognostic significance of positive lymph node number in early cervical cancer JUNG WOO PARK and JONG WOON BAE Department of Obstetrics and Gynecology, Dong A University Hospital, Dong A University
More informationAOGS MAIN RESEARCH ARTICLE
A C TA Obstetricia et Gynecologica AOGS MAIN RESEARCH ARTICLE Differential clinical characteristics, treatment response and prognosis of locally advanced adenocarcinoma/ adenosquamous carcinoma and squamous
More informationA phase II study of weekly paclitaxel and cisplatin followed by radical hysterectomy in stages IB2 and IIA2 cervical cancer AGOG14-001/TGOG1008
A phase II study of weekly paclitaxel and cisplatin followed by radical hysterectomy in stages IB2 and IIA2 cervical cancer AGOG14-001/TGOG1008 NCT02432365 Chyong-Huey Lai, MD On behalf of Principal investigator
More informationLocally advanced disease & challenges in management
Gynecologic Cancer InterGroup Cervix Cancer Research Network Cervix Cancer Education Symposium, February 2018 Locally advanced disease & challenges in management Carien Creutzberg Radiation Oncology, Leiden
More informationreceive adjuvant chemotherapy
Women with high h risk early stage endometrial cancer should receive adjuvant chemotherapy Michael Friedlander The Prince of Wales Cancer Centre and Royal Hospital for Women The Prince of Wales Cancer
More informationAnalysis of Prognosis and Prognostic Factors of Cervical Adenocarcinoma and Adenosqumous Carcinoma of the Cervix
DOI 10.1007/s11805-009-0133-8 133 Analysis of rognosis and rognostic Factors of Cervical Adenocarcinoma and Adenosqumous Carcinoma of the Cervix Guangwen Yuan Lingying Wu Xiaoguang Li Manni Huang Department
More informationRare Small Cell Carcinoma in Genitourinary Tract: Experience from E-Da Hospital
E-Da Medical Journal 20;():-5 Original Article Rare Small Cell Carcinoma in Genitourinary Tract: Experience from E-Da Hospital Wei-Ting Kuo, I-Wei Chang2, Kevin Lu, Hua-Pin Wang, Tsan-Jung u, Victor C.
More informationChun-Chieh Wang, MD and Feng-Yuan Liu, MD/ Prof. Chyong-Huey Lai, MD
Concept/trial design presentation A Phase 2 Trial of Pembrolizumab Combined with Chemoradiation for Patients with [ 18 F]-FDG PET/CT-defined Poor-prognostic Cervical Cancer Chun-Chieh Wang, MD and Feng-Yuan
More informationThe Effect of Treatment Time in Locally Advanced Cervical Cancer in the Era of Concurrent Chemoradiotherapy
The Effect of Treatment Time in Locally Advanced Cervical Cancer in the Era of Concurrent Chemoradiotherapy Suisui Song, MD 1 ; Sonali Rudra, MD 1 ; Michael D. Hasselle, MD 2 ; Paige L. Dorn, MD 1 ; Loren
More informationThiazolidinediones and the risk of bladder cancer: A cohort study. R Mamtani, K Haynes, WB Bilker, DJ Vaughn, BL Strom, K Glanz, JD Lewis
Thiazolidinediones and the risk of bladder cancer: A cohort study R Mamtani, K Haynes, WB Bilker, DJ Vaughn, BL Strom, K Glanz, JD Lewis Study objective To investigate the risk of bladder cancer associated
More informationTreatment of Locally Advanced Rectal Cancer: Current Concepts
Treatment of Locally Advanced Rectal Cancer: Current Concepts James J. Stark, MD, FACP Medical Director, Cancer Program and Palliative Care Maryview Medical Center Professor of Medicine, EVMS Case Presentation
More informationESRA KAYTAN SAĞLAM, MD Istanbul University Oncology Institute
USE OF RADIOSENSITIZERS IN ONCOLOGY ESRA KAYTAN SAĞLAM, MD Istanbul University Oncology Institute According to cell type: Radiosensitive tumors (embryojenic tumors, lymphomas) Moderate sensitives (Squamous
More informationThe Egyptian Journal of Hospital Medicine (July 2018) Vol. 72 (9), Page
The Egyptian Journal of Hospital Medicine (July 2018) Vol. 72 (9), Page 5298-5303 Prognostic Value of Platelet to Lymphocyte Ratio in Patients with Non-Small Cell Lung Cancer Mohammad Sabry Elkady, Ghada
More informationClinical Discussion. Dr Pankaj Chaturvedi. Professor and Surgeon Tata Memorial Hospital
Clinical Discussion Dr Pankaj Chaturvedi Professor and Surgeon Tata Memorial Hospital chaturvedi.pankaj@gmail.com 47/M/smoker Hopkins : Transglottic lesion No cartilage infiltration but sclerosis Left
More informationRisk group criteria for tailoring adjuvant treatment in patients with endometrial cancer : a validation study of the GOG criteria
Risk group criteria for tailoring adjuvant treatment in patients with endometrial cancer : a validation study of the GOG criteria Suk-Joon Chang, MD, Hee-Sug Ryu MD Gynecologic Cancer Center Department
More informationDevelopment and ini.al valida.on of a prognos.c nomogram for ambulatory pa.ents with advanced cancer
Session: What Does the Future Hold? Prognos7ca7on in Advanced Cancer and Clinical Decision Making Development and ini.al valida.on of a prognos.c nomogram for ambulatory pa.ents with advanced cancer Paiva
More informationStaging. Carcinoma confined to the corpus. Carcinoma confined to the endometrium. Less than ½ myometrial invasion. Greater than ½ myometrial invasion
5 th of June 2009 Background Most common gynaecological carcinoma in developed countries Most cases are post-menopausal Increasing incidence in certain age groups Increasing death rates in the USA 5-year
More informationClinical Study on Prognostic Factors and Nursing of Breast Cancer with Brain Metastases
Clinical Study on Prognostic Factors and Nursing of Breast Cancer with Brain Metastases Ying Zhou 1#, Kefang Zhong 1#, Fang Zhou* 2 ABSTRACT This paper aims to explore the clinical features and prognostic
More informationBiomarkers and undiagnosed disease
Biomarkers and undiagnosed disease Soham Al Snih, MD, Ph.D The University of Texas Medical Branch, Galveston, TX May 29, 2015 Mexico City, Mexico Biomarkers Broad subcategory of medical signs Objective
More informationPalliative radiotherapy near the end of life for brain metastases from lung cancer: a populationbased
Palliative radiotherapy near the end of life for brain metastases from lung cancer: a populationbased analysis Roel Schlijper Fellow Radiation Oncology BC Cancer, Prince George Disclosures No conflicts
More informationGhadjar et al. Radiation Oncology (2015) 10:21 DOI /s y
Ghadjar et al. Radiation Oncology (2015) 10:21 DOI 10.1186/s13014-014-0319-y RESEARCH Open Access Impact of weight loss on survival after chemoradiation for locally advanced head and neck Cancer: secondary
More informationABSTRACT. Shuisheng Zhang 1, Xiaozhun Huang 2, Yuan Tian 3, Saderbieke Aimaiti 1, Jianwei Zhang 1, Jiuda Zhao 4, Yingtai Chen 1 and Chengfeng Wang 1
Clinicopathologic characteristics, laboratory parameters, treatment protocols, and outcomes of pancreatic cancer: a retrospective cohort study of 1433 patients in China Shuisheng Zhang 1, Xiaozhun Huang
More informationIndeterminate Pulmonary Nodules in Patients with Colorectal Cancer
Indeterminate Pulmonary Nodules in Patients with Colorectal Cancer Jai Sule 1, Kah Wai Cheong 2, Stella Bee 2, Bettina Lieske 2,3 1 Dept of Cardiothoracic and Vascular Surgery, University Surgical Cluster,
More informationHead and Neck Reirradiation: Perils and Practice
Head and Neck Reirradiation: Perils and Practice David J. Sher, MD, MPH Department of Radiation Oncology Dana-Farber Cancer Institute/ Brigham and Women s Hospital Conflicts of Interest No conflicts of
More informationGynecologic Cancer InterGroup Cervix Cancer Research Network. Management of Cervical Cancer in Resource Limited Settings.
Management of Cervical Cancer in Resource Limited Settings Linus Chuang MD Conflict of Interests None Cervical cancer is the fourth most common malignancy in women worldwide 530,000 new cases per year
More informationChapter 8 Adenocarcinoma
Page 80 Chapter 8 Adenocarcinoma Overview In Japan, the proportion of squamous cell carcinoma among all cervical cancers has been declining every year. In a recent survey, non-squamous cell carcinoma accounted
More informationSurgical Management of Metastatic Colon Cancer: analysis of the Surveillance, Epidemiology and End Results (SEER) database
Surgical Management of Metastatic Colon Cancer: analysis of the Surveillance, Epidemiology and End Results (SEER) database Hadi Khan, MD 1, Adam J. Olszewski, MD 2 and Ponnandai S. Somasundar, MD 1 1 Department
More informationCorrespondence should be addressed to Dae Sik Yang;
Hindawi BioMed Research International Volume 2017, Article ID 2917925, 9 pages https://doi.org/10.1155/2017/2917925 Clinical Study Validation of Nomograms for Survival and Metastases after Hysterectomy
More informationPlattenepithelkarzinom des Ösophagus, 1 st -line
Plattenepithelkarzinom des Ösophagus, 1 st -line AIO-STO-0309 An open-label, randomized phase III trial of cisplatin and 5-fluorouracil with or without panitumumab for patients with nonresectable, advanced
More informationORIGINAL PAPER. Department of Radiology, Nagoya University Graduate School of Medicine, Aichi, Japan 2
Nagoya J. Med. Sci. 79. 211 ~ 220, 2017 doi:10.18999/nagjms.79.2.211 ORIGINAL PAPER Postoperative chemoradiation therapy using high dose cisplatin and fluorouracil for high- and intermediate-risk uterine
More informationTherapeutic Use of Metformin in Diabetes and Survival Outcomes in Endometrial Cancer Patients with Diabetes
DOI:10.22034/APJCP.2018.19.5.1295 Metformin in Endometrial Cancer RESEARCH ARTICLE Editorial Process: Submission:10/27/2017 Acceptance:04/17/2018 Therapeutic Use of Metformin in Diabetes and Survival Outcomes
More informationMinimum absolute lymphocyte count during radiotherapy as a new prognostic factor for nasopharyngeal cancer
ORIGINAL ARTICLE Minimum absolute lymphocyte count during radiotherapy as a new prognostic factor for nasopharyngeal cancer Oyeon Cho, MD, Young-Taek Oh, MD, PhD,* Mison Chun, MD, PhD, O-Kyu Noh, MD, PhD,
More informationAmerican Head and Neck Society - Journal Club Volume 22, July 2018
- Table of Contents click the page number to go to the summary and full article link. Location and Causation of Residual Lymph Node Metastasis After Surgical Treatment of Regionally Advanced Differentiated
More informationPrognostic significance of K-Ras mutation rate in metastatic colorectal cancer patients. Bruno Vincenzi Università Campus Bio-Medico di Roma
Prognostic significance of K-Ras mutation rate in metastatic colorectal cancer patients Bruno Vincenzi Università Campus Bio-Medico di Roma Colorectal cancer 3 rd most common cancer worldwide Approximately
More informationUvA-DARE (Digital Academic Repository) Prognostic factors in cervical cancer Biewenga, Petra. Link to publication
UvA-DARE (Digital Academic Repository) Prognostic factors in cervical cancer Biewenga, Petra Link to publication Citation for published version (APA): Biewenga, P. (2015). Prognostic factors in cervical
More informationSupplementary Appendix
Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Long GV, Hauschild A, Santinami M, et al. Adjuvant dabrafenib
More informationCarcinosarcoma Trial rial in s a in rare malign rare mali ancy
Carcinosarcoma Trials in a rare malignancy BACKGROUND Rare and highly aggressive epithelial malignancies Biphasic tumors with epithelial and mesenchymal components Uterine carcinomas (UCS) uncommon with
More informationPTCOG 46. Educational Workshop Session IV. Head & Neck CLINICAL. J. Mizoe (NIRS, Japan)
PTCOG 46 Educational Workshop Session IV CLINICAL Head & Neck J. Mizoe (NIRS, Japan) Photon X-Ray γ-ray Fast Neutron Non-Charged Radiation Electron Proton Helium Light Ion Heavy Particle Carbon Neon Argon
More informationLymphoma Case Scenario 1
Lymphoma Case Scenario 1 HISTORY: A 23-year-old healthy female presented with a month-long history of persistent headache of increasing severity. She noted episodic nausea and vomiting in association with
More informationKe Hu, Weiping Wang, Xiaoliang Liu, Qingyu Meng and Fuquan Zhang *
Hu et al. Radiation Oncology (2018) 13:249 https://doi.org/10.1186/s13014-018-1197-5 RESEARCH Open Access Comparison of treatment outcomes between squamous cell carcinoma and adenocarcinoma of cervix after
More informationRadiation Therapy for Liver Malignancies
Outline Radiation Therapy for Liver Malignancies Albert J. Chang, M.D., Ph.D. Department of Radiation Oncology, UCSF March 23, 2014 Rationale for developing liver directed therapies Liver directed therapies
More informationAdjuvant Therapies in Endometrial Cancer. Emma Hudson
Adjuvant Therapies in Endometrial Cancer Emma Hudson Endometrial Cancer Most common gynaecological cancer Incidence increasing in Western world 1-2% cancer deaths 75% patients postmenopausal 97% epithelial
More informationTae-Wook Kong 1,2, Joo-Hyuk Son 1,2, Jiheum Paek 1,2, Yonghee Lee 1,3, Eun Ju Lee 1,4, Suk-Joon Chang 1,2, Hee-Sug Ryu 1,2
Preoperative nomogram for individualized prediction of parametrial invasion in patients with FIGO stage IB cervical cancer treated with radical hysterectomy Tae-Wook Kong 1,2, Joo-Hyuk Son 1,2, Jiheum
More informationIs Ovarian Preservation Feasible in Early-Stage Adenocarcinoma of the Cervix?
e-issn 1643-3750 DOI: 10.12659/MSM.897291 Received: 2015.12.27 Accepted: 2016.01.13 Published: 2016.02.08 Is Ovarian Preservation Feasible in Early-Stage Adenocarcinoma of the Cervix? Authors Contribution:
More informationCharacterization of Patients with Poor-
Characterization of Patients with Poor- Risk Metastatic Renal Cell Carcinoma Hamieh L 1 *, McKay RR 1 *, Lin X 2, Simantov R 2, Choueiri TK 1 *Equal contributions 1 Dana-Farber Cancer Institute, Boston,
More informationCharacteristics and prognostic factors of synchronous multiple primary esophageal carcinoma: A report of 52 cases
Thoracic Cancer ISSN 1759-7706 ORIGINAL ARTICLE Characteristics and prognostic factors of synchronous multiple primary esophageal carcinoma: A report of 52 cases Mei Li & Zhi-xiong Lin Department of Radiation
More informationPelvic palliative radiotherapy for gynecological cancers present state of knowledge and pending research questions to answer
Pelvic palliative radiotherapy for gynecological cancers present state of knowledge and pending research questions to answer Esten S. Nakken MD PhD Division of Cancer Medicine Oslo University Hospital
More informationRadiation therapy with chemotherapy for patients with cervical cancer and supraclavicular lymph node involvement
Original Article J Gynecol Oncol Vol. 23, No. 3:159-167 pissn 2005-0380 eissn 2005-0399 Radiation therapy with chemotherapy for patients with cervical cancer and supraclavicular lymph node involvement
More informationPILOT STUDY OF CONCURRENT CHEMO-RADIOTHERAPY FOR ADVANCED NASOPHARYNGEAL CARCINOMA (Forum for Nuclear Cooperation in Asia)
PILOT STUDY OF CONCURRENT CHEMO-RADIOTHERAPY FOR ADVANCED NASOPHARYNGEAL CARCINOMA (Forum for Nuclear Cooperation in Asia) Dr. Miriam Joy C. Calaguas Dept. of Radiation Oncology St. Luke s Medical Center
More informationDr Aftab Ahmad Consultant Diabetologist at Royal Liverpool University Hospital Regional Diabetes Network Lead
Dr Aftab Ahmad Consultant Diabetologist at Royal Liverpool University Hospital Regional Diabetes Network Lead Today s Presentation HbA1c & diagnosing Diabetes What is Impaired Glucose & IGR? Implications
More informationPET-adapted therapies in the management of younger patients (age 60) with classical Hodgkin lymphoma
PET-adapted therapies in the management of younger patients (age 60) with classical Hodgkin lymphoma Ryan Lynch MD Assistant Professor, University of Washington Assistant Member, Fred Hutchinson Cancer
More informationThe Younger Patients Have More Better Prognosis in Limited Disease Small Cell Lung Cancer
ORIGINAL ARTICLE http://dx.doi.org/10.4046/trd.2016.79.4.274 ISSN: 1738-3536(Print)/2005-6184(Online) Tuberc Respir Dis 2016;79:274-281 The Younger Patients Have More Better Prognosis in Limited Disease
More informationTREATMENT TIME & TOBACCO: TWIN TERRORS Of H&N Therapy
TREATMENT TIME & TOBACCO: TWIN TERRORS Of H&N Therapy Anurag K. Singh, MD Professor of Medicine University at Buffalo School of Medicine Professor of Oncology Director of Radiation Research Roswell Park
More informationPrognostic value of clinicopathological characteristics in patients with pancreatic cancer
Original Article rognostic value of clinicopathological characteristics in patients with pancreatic cancer Mei Geng 1, Haoping Xu 1, Ruobing Ren 1, Qing Qu 1, Chengfang Shangguan 1, Junwei Wu 1, Jinsong
More informationCombined drug and ionizing radiation: biological basis. Prof. Vincent GREGOIRE Université Catholique de Louvain, Cliniques Universitaires St-Luc
Combined drug and ionizing radiation: biological basis Prof. Vincent GREGOIRE Université Catholique de Louvain, Cliniques Universitaires St-Luc Pelvic radiation with concurrent chemotherapy compared with
More information窑 Original Article 窑. Jun Ma 1,2 鄢. , Zhe Sheng Wen 1,2, Peng Lin 1,2, Xin Wang 1,2, Fang Yun Xie 1,3. 揖 Abstract 铱 Background and Objective: Methods:
窑 Original Article 窑 Chinese Journal of Cancer The results and prognosis of different treatment modalities for solitary metastatic lung tumor from nasopharyngeal carcinoma: a retrospective study of 5 cases
More informationMIDWESTERN MEDICAL DIRECTOR S ASSOCIATION. May 1 and 2, 2014 Northbrook, IL
MIDWESTERN MEDICAL DIRECTOR S ASSOCIATION May 1 and 2, 2014 Northbrook, IL Why Everyone Loves the Midwestern Medical Director s Association! Title of presentation and name of speaker 21/04/2014 2 Northern
More informationAdjuvant Therapy in Locally Advanced Head and Neck Cancer. Ezra EW Cohen University of Chicago. Financial Support
Adjuvant Therapy in Locally Advanced Head and Neck Cancer Ezra EW Cohen University of Chicago Financial Support This program is made possible by an educational grant from Eli Lilly Oncology, who had no
More informationUtility of 18 F-FDG PET/CT in metabolic response assessment after CyberKnife radiosurgery for early stage non-small cell lung cancer
Utility of F-FDG PET/CT in metabolic response assessment after CyberKnife radiosurgery for early stage non-small cell lung cancer Ngoc Ha Le 1*, Hong Son Mai 1, Van Nguyen Le 2, Quang Bieu Bui 2 1 Department
More informationRadiation and Hodgkin s Disease: A Changing Field. Sravana Chennupati Radiation Oncology PGY-2
Radiation and Hodgkin s Disease: A Changing Field Sravana Chennupati Radiation Oncology PGY-2 History of Present Illness 19 yo previously healthy male college student began having pain in his R shoulder
More informationThe Prognostic Impact of Neutrophil Lymphocytic Ratio (NLR) on Survival of Patients with Glioblastoma Multiforme (GBM): A Retrospective Cohort Study
Cancer and Clinical Oncology; Vol. 6, No. 2; 2017 ISSN 1927-4858 E-ISSN 1927-4866 Published by Canadian Center of Science and Education The Prognostic Impact of Neutrophil Lymphocytic Ratio (NLR) on Survival
More informationPatient age and cutaneous malignant melanoma: Elderly patients are likely to have more aggressive histological features and poorer survival
MOLECULAR AND CLINICAL ONCOLOGY 7: 1083-1088, 2017 Patient age and cutaneous malignant melanoma: Elderly patients are likely to have more aggressive histological features and poorer survival FARUK TAS
More informationWhat is endometrial cancer?
Uterine cancer What is endometrial cancer? Endometrial cancer is the growth of abnormal cells in the lining of the uterus. The lining is called the endometrium. Endometrial cancer usually occurs in women
More informationElevated Serum Levels of Adropin in Patients with Type 2 Diabetes Mellitus and its Association with
Elevated Serum Levels of Adropin in Patients with Type 2 Diabetes Mellitus and its Association with Insulin Resistance Mehrnoosh Shanaki, Ph.D. Assistant Professor of Clinical Biochemistry Shahid Beheshti
More informationClinician Blood Panel Results
Page 1 of 7 Blood Panel - Markers Out of Range and Patterns (Pattern: proprietary formula using one or more Blood Markers) Blood Panel: Check for Markers that are out of Lab Range ***NOTE*** Only one supplement
More informationModalities of Radiation
Modalities of Radiation Superficial radiotherapy Orthovoltage Megavoltage Photons Electrons Brachytherapy Interstitial Moulds When to refer? The vast majority of skin cancers will be managed without any
More informationAdjuvant Chemotherapy
State-of-the-art: standard of care for resectable NSCLC Adjuvant Chemotherapy JY DOUILLARD MD PhD Professor of Medical Oncology Integrated Centers of Oncology R Gauducheau University of Nantes France Adjuvant
More informationSupplementary Appendix to manuscript submitted by Trappe, R.U. et al:
Supplementary Appendix to manuscript submitted by Trappe, R.U. et al: Response to rituximab induction is a predictive marker in B-cell post-transplant lymphoproliferative disorder and allows successful
More informationESM Table 2 Data extraction form and key data from included studies
ESM Table 2 Data extraction form and key data from included studies Author, year and title Behan, 2006 [21] Cessation of menstruation improves the correlation of FPG to hemoglobin A 1c in Caucasian women
More informationRelapse Patterns and Outcomes Following Recurrence of Endometrial Cancer in Northern Thai Women
DOI:http://dx.doi.org/10.7314/APJCP.2015.16.9.3861 Relapse Patterns and Outcomes Following Recurrence of Endometrial Cancer in Northern Thai Women RESEARCH ARTICLE Relapse Patterns and Outcomes Following
More informationOriginal Article.
Original Article J Gynecol Oncol Vol. 24, No. 4:313-320 pissn 2005-0380 eissn 2005-0399 Posttreatment cut-off levels of squamous cell carcinoma antigen as a prognostic factor in patients with locally advanced
More informationBest Papers. F. Fusco
Best Papers UROLOGY F. Fusco Best papers - 2015 RP/RT Oncological outcomes RP/RT IN ct3 Utilization trends RP/RT Complications Evolving role of elnd /Salvage LND This cohort reflects the current clinical
More informationCervical CA: What is Advanced Stage? If the tumor is early stage but >4cm (IB2 or IIA2), it is often treated as advanced stage (category 1) but also h
PROGRAMA 2 Taller Internacional Multidisciplinario de Cancer de Mama y Cuello Uterino Racional del tratamiento combinado con Quimioterapia e Irradiación. Resultados en Cáncer de Cérvix avanzado Higinia
More informationPrognostic significance of stroma tumorinfiltrating lymphocytes according to molecular subtypes of breast cancer
Prognostic significance of stroma tumorinfiltrating lymphocytes according to molecular subtypes of breast cancer Hee Jung Kwon, Nuri Jang, Min Hui Park, Young Kyung Bae Department of Pathology, Yeungnam
More informationSalvage prostatectomy for post-radiation adenocarcinoma with treatment effect: Pathological and oncological outcomes
ORIGINAL RESEARCH Salvage prostatectomy for post-radiation adenocarcinoma with treatment effect: Pathological and oncological outcomes Michael J. Metcalfe, MD ; Patricia Troncoso, MD 2 ; Charles C. Guo,
More informationPredictors in Determining Recurrence of Pancreatic Cancer
Predictors in Determining Recurrence of Pancreatic Cancer Lesly Almanzar Kean University Reed Johnson Luther College Alexandria Leonhardt Cornell College Evelyn Rodriguez Correa Pontifical Catholic University
More informationProstate Case Scenario 1
Prostate Case Scenario 1 H&P 5/12/16: A 57-year-old Hispanic male presents with frequency of micturition, urinary urgency, and hesitancy associated with a weak stream. Over the past several weeks, he has
More informationNon-small Cell Lung Cancer in the Young: A Retrospective Analysis of Diagnosis, Management and Outcome Data
ANTICANCER RESECH 26: 3175-3182 (2006) Non-small Cell Lung Cancer in the Young: A Retrospective Analysis of Diagnosis, Management and Outcome Data D. MAURI, G. PENTHEROUDAKIS, D. BAFALOUKOS, D. PECTASIDES,
More information